Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity.

Arterioscler Thromb Vasc Biol

Deparment of di Biochimica e Biologia Molecolare, Università di Ferrara, Via L. Borsari 46, 44100 Ferrara, Italia.

Published: March 2005

Objective: Diurnal variations in levels of factor VII (FVII), FVIII, proteins C and S, antithrombin, plasminogen activator inhibitor-1, prothrombin fragment F1+2, and D-dimers in healthy humans point to the existence of circadian rhythms of coagulation factors. We sought for temporal fluctuations of tissue factor pathway inhibitor (TFPI) activity in human and mouse plasma.

Methods And Results: TFPI activity showed significant daily variations with highest levels in the morning in healthy men (+11%) and in mice at the light-to-dark transition (+63%), the beginning of the physically active period. Variations in FVII activity paralleled those in TFPI. In mice, the feeding schedule had a strong impact on these rhythms. Although restricted feeding and fasting shifted the peak of TFPI, the FVII peak disappeared. Investigation of temporal fluctuations in constant darkness indicated the existence of daily rhythms for TFPI and of true circadian rhythms for FVII.

Conclusions: For the first time, we report, both in humans and mice, temporal variations in TFPI activity. The coherent variations in FVII and TFPI activity could interplay to maintain the coagulation equilibrium. The chronobiological patterns should be considered to analyze activity levels of these factors. Moreover, the mouse model could be exploited to investigate modifiers of coagulation rhythms potentially associated to morning peaks of cardiovascular events.

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.ATV.0000153140.13148.e0DOI Listing

Publication Analysis

Top Keywords

tfpi activity
16
circadian rhythms
12
tissue factor
8
factor pathway
8
pathway inhibitor
8
factor vii
8
temporal fluctuations
8
variations fvii
8
activity
7
tfpi
7

Similar Publications

Clinical Rationale For Study: We have reported that intracerebral haemorrhage (ICH) of unknown cause at a young age is associated with lower prothrombin and factor VII and higher antithrombin activity, along with the formation of looser fibrin networks displaying enhanced lysability. Patients with mild-to-moderate bleeding of unknown cause have elevated levels of free plasma tissue factor pathway inhibitor alpha (fTFPIα), inhibiting the tissue factor-factor VII complex and prothrombinase.

Aim Of Study: We hypothesised that patients with an intracerebral haemorrhage (ICH) of unknown cause may also exhibit higher fTFPIα.

View Article and Find Full Text PDF

Atrial Fibrillation (AF) induces proinflammatory processes which incite vascular endothelial activation and dysfunction. This study seeks to examine the potential relationship between various endothelial, inflammatory, thrombotic, and renin-angiotensin-system (RAS) biomarkers in AF patients.Blood samples were from AF patients (n = 110) prospectively enrolled in this study prior to their first AF ablation.

View Article and Find Full Text PDF
Article Synopsis
  • Sepsis-induced DIC is a serious condition with high morbidity and mortality, and factors like endothelial injury and extracellular vesicles (EV) are crucial in its development.
  • The study examined the role of E-selectin, EV, tissue factor (TF), and tissue factor pathway inhibitor (TFPI) in identifying sepsis-induced coagulopathy by analyzing plasma samples from 87 sepsis patients.
  • Findings indicated that while only TFPI and TF-PCA levels could effectively discriminate between patients with and without DIC, higher levels of TFPI specifically correlated with worsening DIC, suggesting that these markers could enhance diagnosis and treatment strategies in septic patients.
View Article and Find Full Text PDF
Article Synopsis
  • - Neutrophils can release their DNA and contents to fight infections, but this can impact blood coagulation through a protein called TFPI, which is affected by an enzyme (PAD4) that alters (citrullinates) it, reducing its ability to prevent blood clotting.
  • - The study aimed to explore how this citrullination affects TFPI's performance in inhibiting key components of blood coagulation, specifically FXa and the FVIIa/tissue factor complex, using various laboratory techniques.
  • - Results showed that while citrullination severely weakened TFPI's ability to inhibit FXa, it still had some effect on FVIIa/tissue factor activity with the help of another protein (
View Article and Find Full Text PDF

Protective effects of tissue factor pathway inhibitor on mice with lipopolysaccharide-induced acute lung injury.

Exp Cell Res

January 2025

Department of Thoracic and Cardiovascular Surgery, Huashan Hospital, Affiliated with Fudan University, Shanghai, 200040, China. Electronic address:

Acute lung injury (ALI) resulting from bacterial infection poses a significant risk, and its etiology involves the complex interplay of harmful immune responses and blood coagulation. Despite this understanding, the roles and mechanisms of tissue factor pathway inhibitor (TFPI) in LPS-induced ALI remain insufficiently elucidated. In this study, we aimed to explore the effects of TFPI in LPS-induced ALI.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!